NCT00662714 Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE3
NCT00660374 Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00659295 Observational Study to Evaluate the Safety of Levemir® in Diabetes Status COMPLETED Phase N/A
NCT00659282 Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes Status COMPLETED Phase N/A
NCT00658099 Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard® Status COMPLETED Phase N/A
NCT00657930 Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir) Status COMPLETED Phase N/A
NCT00657319 Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins Status COMPLETED Phase N/A
NCT00655200 Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT00655044 Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes Status COMPLETED Phase N/A
NCT00654121 Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives Status COMPLETED Phase PHASE2
NCT00639626 Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD) Status TERMINATED Phase PHASE2/PHASE3
NCT00634842 Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily Status COMPLETED Phase PHASE4
NCT00627445 Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00625040 Incretin Physiology and Beta-cell Function Before and After Weight-loss Status TERMINATED Phase N/A
NCT00624364 Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00623194 Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689 Status COMPLETED Phase PHASE3
NCT00620282 The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00619697 Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00617565 Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes Status COMPLETED Phase PHASE3